Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Nov;151(5):1417-23.

Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis

Affiliations

Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis

F Pezzella et al. Am J Pathol. 1997 Nov.

Abstract

Neoplastic growth is usually dependent on blood supply, and it is commonly accepted that this is provided by the formation of new vessels. However, tumors may be able to grow without neovascularization if they find a suitable vascular bed available. We have investigated the pattern of vascularization in a series of 500 primary stage I non-small-cell lung carcinomas. Immunostaining of endothelial cells has highlighted four distinct patterns of vascularization. Three patterns (which we called basal, papillary, and diffuse) have in common the destruction of normal lung and the production of newly formed vessels and stroma. The fourth pattern, which we called alveolar or putative nonangiogenic, was observed in 16% (80/500) of the cases and is characterized by lack of parenchymal destruction and absence of both tumor associated stroma and new vessels. The only vessels present were the ones in the alveolar septa, and their presence highlighted, through the whole tumor, the lung alveoli filled up by the neoplastic cells. This observation suggests that, if an appropriate vascular bed is available, a tumor can exploit it and grows without inducing neo-angiogenesis. This could have implications for strategies aimed at inhibiting tumor growth by vascular targeting or inhibition of angiogenesis.

PubMed Disclaimer

References

    1. J Pathol. 1996 May;179(1):80-8 - PubMed
    1. J Pathol. 1995 Nov;177(3):275-83 - PubMed
    1. Eur J Cancer. 1996 Dec;32A(14):2494-500 - PubMed
    1. J Clin Oncol. 1997 Aug;15(8):2858-65 - PubMed
    1. N Engl J Med. 1971 Nov 18;285(21):1182-6 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources